Respiratory Syncytial Virus Vaccines in Adults Who Are Not Pregnant or Immunocompromised: Rapid Practice Points From the American College of Physicians

Annals of Internal Medicine 2026

View at publisher
Authors: Amir Qaseem, Adam J. Obley, Curtis S. Harrod, Timothy J Wilt, Kate Carroll, Linda L. Humphrey, Amir Qaseem, Adam J. Obley, Curtis S. Harrod, Timothy J Wilt, Kate Carroll, Linda L. Humphrey
+16 more Ray Haeme, Christopher D. Jackson, Devan Kansagara, Alysa Krain, Katherine Mackey, Thejaswi Poonacha, Sameer D. Saini, Chelsea Vigna, Ray Haeme, Christopher D. Jackson, Devan Kansagara, Alysa Krain, Katherine Mackey, Thejaswi Poonacha, Sameer D. Saini, Chelsea Vigna
DOI: 10.7326/annals-25-05485
Cited by: 2
References: 10

Abstract

DESCRIPTION: The American College of Physicians (ACP) developed these rapid practice points addressing the efficacy, comparative effectiveness, and harms of respiratory syncytial virus (RSV) vaccines in adults aged 18 years or older who are not pregnant or immunocompromised. METHODS: The ACP Population Health and Medical Science Committee developed the rapid practice points based on a rapid review by the ACP Center for Evidence Reviews at Cochrane Austria. The practice points apply to adults aged 60 years or older who are not immunocompromised.

Fields of Study & Subjects

Respiratory viral infections research COVID-19 Impact on Reproduction Delphi Technique in Research

Publication details

Journal / source
Annals of Internal Medicine
Publisher
American College of Physicians
Volume
179
Issue
5
Pages
734–739
Publication date
2 March 2026
Language
EN